Pathway of care of hepatocellular carcinoma in 2017.
作者信息
Invernizzi Federica, Colombo Massimo
机构信息
Cattedra di Gastroenterologia Universita degli Studi di Milano, Milan, Italy.
Humanitas Clinical & Research Center, Rozzano, Italy.
出版信息
Hepat Oncol. 2016 Oct;3(4):217-221. doi: 10.2217/hep-2017-0004. Epub 2017 Jun 21.
Abstract
摘要
相似文献
1
Pathway of care of hepatocellular carcinoma in 2017.2017年肝细胞癌的治疗路径
Hepat Oncol. 2016 Oct;3(4):217-221. doi: 10.2217/hep-2017-0004. Epub 2017 Jun 21.
2
[Study of the risk factors for recurrence of early and late stage hepatocellular carcinoma after hepatic artery embolization combined with radiofrequency ablation therapy].肝动脉栓塞联合射频消融治疗后早期和晚期肝细胞癌复发危险因素的研究
Zhonghua Gan Zang Bing Za Zhi. 2021 Oct 20;29(10):1001-1005. doi: 10.3760/cma.j.cn501113-20200407-00163.
3
Treatment strategy for hepatocellular carcinoma in China: radiofrequency ablation versus liver resection.中国肝细胞癌的治疗策略：射频消融与肝切除术对比
Jpn J Clin Oncol. 2016 Dec;46(12):1075-1080. doi: 10.1093/jjco/hyw134. Epub 2016 Sep 27.
4
Radiofrequency (thermal) ablation versus no intervention or other interventions for hepatocellular carcinoma.射频（热）消融术与不干预或其他干预措施治疗肝细胞癌的比较
Cochrane Database Syst Rev. 2013 Dec 19;2013(12):CD003046. doi: 10.1002/14651858.CD003046.pub3.
5
Treatment effect of radiofrequency ablation versus liver transplantation and surgical resection for hepatocellular carcinoma within Milan criteria: a population-based study.射频消融与肝移植和手术切除治疗米兰标准内肝细胞癌的疗效比较：一项基于人群的研究。
Eur Radiol. 2021 Jul;31(7):5379-5389. doi: 10.1007/s00330-020-07551-9. Epub 2021 Jan 6.
6
An explorative data-analysis to support the choice between hepatic resection and radiofrequency ablation in the treatment of hepatocellular carcinoma.探索性数据分析以支持肝癌治疗中肝切除术与射频消融术的选择。
Dig Liver Dis. 2014 Mar;46(3):257-63. doi: 10.1016/j.dld.2013.10.015. Epub 2013 Nov 24.
7
Cost-benefit analysis of hepatic resection, radiofrequency ablation and liver transplantation in small hepatocellular carcinoma.小肝癌肝切除、射频消融与肝移植的成本效益分析。
Expert Rev Pharmacoecon Outcomes Res. 2022 Mar;22(2):307-313. doi: 10.1080/14737167.2021.1973432. Epub 2021 Oct 14.
8
Liver resection radiofrequency ablation in single hepatocellular carcinoma of posterosuperior segments in elderly patients.老年患者肝后上段单发性肝细胞癌的肝切除及射频消融治疗
World J Gastrointest Surg. 2021 Dec 27;13(12):1696-1707. doi: 10.4240/wjgs.v13.i12.1696.
9
[Treatment of postoperative recurrence of hepatocellular carcinoma with radiofrequency ablation comparing with repeated surgical resection].[射频消融与再次手术切除治疗肝细胞癌术后复发的比较]
Zhonghua Wai Ke Za Zhi. 2008 Nov 1;46(21):1614-6.
10
Laparoscopic staging and radiofrequency of hepatocellular carcinoma in liver ci rrhosis. A "bridge" treatment to liver transplantation.肝硬化患者肝细胞癌的腹腔镜分期及射频治疗。肝移植的“桥梁”治疗。
Hepatogastroenterology. 2009 May-Jun;56(91-92):793-7.
本文引用的文献
1
Corrigendum to 'EASL recommendations on treatment of hepatitis C: Final update of the series [J Hepatol 73 (2020) 1170-1218].《欧洲肝脏研究学会丙型肝炎治疗推荐：系列最终更新版》勘误 [《肝脏病学杂志》73卷（2020年）1170 - 1218页]
J Hepatol. 2023 Feb;78(2):452. doi: 10.1016/j.jhep.2022.10.006. Epub 2022 Dec 1.
2
Hepatitis C treatment and liver cancer recurrence: cause for concern?丙型肝炎治疗与肝癌复发：值得关注的问题？
Lancet Gastroenterol Hepatol. 2017 Feb;2(2):78-80. doi: 10.1016/S2468-1253(16)30204-7. Epub 2017 Jan 12.
3
AASLD guidelines for the treatment of hepatocellular carcinoma.美国肝病研究学会肝细胞癌治疗指南。
Hepatology. 2018 Jan;67(1):358-380. doi: 10.1002/hep.29086.
4
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial.regorafenib 用于索拉非尼治疗后进展的肝细胞癌患者（RESORCE）：一项随机、双盲、安慰剂对照、3 期试验。
Lancet. 2017 Jan 7;389(10064):56-66. doi: 10.1016/S0140-6736(16)32453-9. Epub 2016 Dec 6.
5
Effectiveness of surveillance for hepatocellular carcinoma in clinical practice: A United States cohort.临床实践中肝细胞癌监测的有效性：一项美国队列研究。
J Hepatol. 2016 Dec;65(6):1148-1154. doi: 10.1016/j.jhep.2016.07.025. Epub 2016 Jul 29.
6
Hierarchic Interaction of Factors Associated With Liver Decompensation After Resection for Hepatocellular Carcinoma.肝癌切除术后肝失代偿相关因素的层次交互作用。
JAMA Surg. 2016 Sep 1;151(9):846-53. doi: 10.1001/jamasurg.2016.1121.
7
Squaring the circle of selection and allocation in liver transplantation for HCC: An adaptive approach.肝移植治疗肝癌中选择与分配难题的解决：一种适应性方法。
Hepatology. 2016 May;63(5):1707-17. doi: 10.1002/hep.28420. Epub 2016 Feb 26.
8
Perspective of laparoscopic liver resection for hepatocellular carcinoma.肝细胞癌腹腔镜肝切除的前景
World J Gastrointest Surg. 2015 Jul 27;7(7):102-6. doi: 10.4240/wjgs.v7.i7.102.
9
Transcatheter Arterial Chemoembolization Plus Radiotherapy Compared With Chemoembolization Alone for Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.经导管动脉化疗栓塞术联合放疗与单纯化疗栓塞术治疗肝细胞癌的系统评价和荟萃分析。
JAMA Oncol. 2015 Sep;1(6):756-65. doi: 10.1001/jamaoncol.2015.2189.
10
Transcatheter arterial chemoembolization combined with radiofrequency ablation delays tumor progression and prolongs overall survival in patients with intermediate (BCLC B) hepatocellular carcinoma.经动脉化疗栓塞联合射频消融可延缓中期（巴塞罗那临床肝癌分期B期）肝细胞癌患者的肿瘤进展并延长总生存期。
BMC Cancer. 2014 Nov 19;14:849. doi: 10.1186/1471-2407-14-849.
Zotero 插件